Decreasing Polypharmacy in Older Adults With Curable Cancers Trial

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

June 14, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Cancer
Interventions
OTHER

Pharmacist-led deprescribing

A pharmacist recruited onto the study will review the patient's current medication list and develop a list of targeted recommendations for deprescribing using the 3-step potentially inappropriate medications identification method.

OTHER

Patient education

Subjects receive a written pamphlet about deprescribing.

Trial Locations (1)

14642

University of Rochester, Rochester

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Rochester

OTHER